Handbook of Neurotoxicity
The Handbook of Neurotoxicity is a reference source for identifying, characterizing, instructing on use, and describing outcomes of neurotoxin treatments – to understand mechanisms associated with toxin use; to project outcomes of neurotoxin treatments; to gauge neurotoxins as predictors of events l...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
New York, NY :
Springer New York : Imprint: Springer,
2014.
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Glutamate as a Neurotoxin,- Methamphetamine and MDMA neurotoxicity: Biochemical and molecular mechanisms
- Microglia: Neuroprotective and Neurodestructive Properties
- Neuroprotection in Demyelinating Diseases: the therapeutic potential of the neurotrophins
- Neurotrophic Factors and Ethanol Neurotoxicity
- Neurotrophic factors and NeuroAIDS: a lesson from brain-derived neurotrophic factor
- Neurotrophins and p75NTR in axonal regeneration and myelination
- Neurotrophins and pain
- Neurotrophin signalling in Cancer
- NGF and immune regulation
- NGF/P75 in cell cycle and tetraploidy
- P75 in neuronal death
- p75NTR processing and signaling: functional role
- p75NTR-A molecule with multiple functions in amyloid-beta metabolism and neurotoxicity
- RCSN Cell System for Identifying Dopaminergic Neurotoxicity
- Seizures tip the balance of neurotrophin signaling towards neuronal death
- Survey of Selective Neurotoxins
- Synthesis, trafficking and release of bdnf
- The Nature of DSP-4-Induced Neurotoxicity
- Trafficking of neurotrophins and their receptors and pathological significance
- TRPV1 activators ("vanilloids") as neurotoxins
- Experimental Approach to Alzheimer Disease
- Iron-induced dopaminergic cell death in vivo as a model of Parkinson´s disease
- Molecular, cellular and behavioural effects produced by perinatal asphyxia: protection by poly (ADP-ribose) polymerase 1 (PARP-1) inhibition
- MPTP: advances from an evergreen neurotoxin
- Multifunctional compounds for Parkinsons disease and Alzheimers disease
- Nanomedicines for Nervous System Diseases
- Neurodegenerative aspects of multiple system atrophy
- Neurotoxic profiles of designer-drugs
- Pathophysiology of obsessive-compulsive disorder: Insights from normal function and neurotoxic effects of drugs, infection and brain injury
- Physical Exercise as Intervention in Parkinsonism
- Protective agents in Parkinson´s disease: caffeine and adenosine A2A receptor antagonists
- Stem Cell Therapies for Age Associated Neurodegeneration
- AIDS
- Excitotoxicity and axon degeneration
- Glutamate Neurotoxicity related to Energy Failure
- Neuroprotection by Kynurenine Metabolites
- Pain
- Quinolinate and related excitotoxins: mechanisms of neurotoxicity and disease relevance
- Role of Ionotropic Glutamate Receptors in Neurodegenerative and Other Disorders
- Tardive Dyskinesia: Outcome of antipsychotic treatment and brain damage?
- The Concept of Excitotoxicity via Glu-R
- The pathogenesis of Alzheimers disease
- 5,6- and 5,7-Dihydroxytryptamines as Serotoninergic Neurotoxins
- Neurotoxicity of Methamphetamine
- Neurotoxic Effects, Mechanisms and Outcome of 192-IgG Saporin
- Neurotrophic therapy for ALS/ MND
- Cancer-mediated neurotoxicity
- Neurotoxicity in psychostimulant and opiate addiction
- Excitotoxicity in HIV associated neurocognitive disorders
- Necroptosis, a potential therapeutic target for neurological disorders
- Epilepsy
- Excitotoxicity and Amyotrophic Lateral Sclerosis
- Excitotoxicity in the Pathogenesis of Autism
- Glutamate Neurotoxicity, Transport and Alternate Splicing of Transporters
- Glutamatergic receptors in Parkinson`s disease
- Ionotropic Receptors in the Central Nervous System and Neurodegenerative Disease
- Lead & excitotoxicity
- Molecular Mechanism and Effects of Clostridial Neurotoxins
- MS & excitotoxicity
- Neuroprotectants Targeting NMDA Receptor Signaling
- Neurotoxicity and ALS: Insights into Pathogenesis
- Schizophrenia
- Neurotoxic Vulnerability Underlying Schizophrenia Spectrum Disorders
- Glutamate in the Pathogenesis of Gliomas
- Neurotoxicity and Neuroprotection in Spinal Cord Injury
- Drug Abuse Neurotoxicity: Alcohol and Nicotine as Developmental Stressors
- Botulinum neurotoxins as therapeutics
- MPTP Neurotoxicity: Actions, Mechanisms and Animal Modeling of Parkinsons disease
- Endogenous Kynurenic acid and Neurotoxicity
- The potential therapeutic effects of statins in Alzheimer's disease
- Drug Treatments for Alzheimer´s Disease: Hopes and Challenges
- Glutamate and Neurodegeneration in the Retina
- Stroke
- Brain trauma Neuroprotection
- Neuroprotective Strategies in Amyotrophic Lateral Sclerosis: Modulation of Neurotransmittory and Neurotrophic Input to Motor Neurons
- The role of Neurotoxicity in Depression
- Advances in stem cell research for Parkinson disease
- Neurotoxicity in Huntington Disease
- Fusion Models and ´Fusioning`in Parkinsonism: Protection and Restoration by Exercise
- Neurotoxicity: a complex multistage process involving different mechanisms.
